subject_line
Help Guide our Activities
First Name
*
Last Name
*
Email Address
*
What are your areas of interest related to HIV and Malignancy?
*
What is your primary area of research?
*
Support with which of the following do you think would be impactful in your research or future grant submissions? (Select all that apply):
*
Collaboration with other HIV and Malignancy investigators
Enrollment of PLWH and cancer in Boston/US
Enrollment of PLWH and cancer in non-US contexts
Cancer-related biospecimens from PLWH
Clinical and outcome data from PLWH and cancer
Access to programmatic/clinical data for diagnosis and care of PLWH with cancer in Boston/US
Please indicate your interest in the following activities. (Select all that apply)
*
Attending quarterly meetings
Collaborating on grant submission/s
Leading subcommittee
Participating in subcommittee
I am not interested in participating
Other, please specify:
Other, please specify:
Would you like to be added to a listserv to receive more information about the HU CFAR HIV and Malignancy Scientific Working Group or other seminars and events in this field?
*
Yes
No
Do you currently have funded HIV and Malignancy related grants? (If so, please indicate grant number(s) and title(s).
What is your primary institutional affiliation?
*
Africa Health Research Institute (AHRI)
Beth Israel Deaconess Medical Center
Boston Children's Hospital
Brigham and Women's Hospital
Botswana Harvard Health Partnership (BHP)
Dana Farber Cancer Institute
Fenway Health
Harvard Medical School
Harvard T.H. Chan School of Public Health
Harvard University
Joslin Diabetes Center
Mass General Hospital
Mbarara University of Science and Technology (MUST)
Ragon Institute of MGH, MIT and Harvard
Other (please specify in the next question)
If Other, please list Institution:
*
What is your area of expertise? (Select all that apply)
*
Basic Science
Clinical
Epidemiologic
Behavioral
Translational
Are you interested in a (potential) diversity supplement submission if eligible?
*
Yes
No
Do you have any additional comments, questions, or suggestions?
Thank you for your feedback!
Visit the
HU CFAR HIV and Malignancy Scientific Working Group
page for more information.